Expert Interview
Discussing the clinical landscape of IPF, with a focus on the use of OFEV and its potential expansion into the pediatric population.
Ticker(s): BOEHRINGER INGELHEIMInstitution: James J Peters VAMC
- Board certified in Internal Medicine, Pulmonary and Critical Care.
- manages treatment for 12 patients with IPF and familliar with avb6, PLN-74809, and other cytokine inhibitors
- Clinical interests include COPD, sleep apnea interface, intestinal lung disease and lung cancer. Hematology, and Oncology
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
